References
- Abnet, C. C., Saadatian-Elahi, M., Pourshams, A., Boffetta, P., Feizzadeh, A., Brennan, P., Taylor, P. R., Kamangar, F., Dawsey, S. M., & Malekzadeh, R. (2004). Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiology and Prevention Biomarkers, 13(6), 1068–1070.
- Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., Hefazi, M., & Motevalian, A. (2016). Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction, 111(10), 1836–1847. https://doi.org/https://doi.org/10.1111/add.13453
- Ashrafi, S., Aminisani, N., Soltani, S., Sarbakhsh, P., Shamshirgaran, S. M., & Rashidi, M.-R. (2018). The validity of self-reported drug use with urine test: results from the pilot phase of Azar cohort study. Health Promotion Perspectives, 8(3), 225–229. https://doi.org/https://doi.org/10.15171/hpp.2018.30
- Bundy, J. D., Bazzano, L. A., Xie, D., Cohan, J., Dolata, J., Fink, J. C., Hsu, C.-Y., Jamerson, K., Lash, J., Makos, G., Steigerwalt, S., Wang, X., Mills, K. T., Chen, J., He, J., & CRIC Study Investigators. (2018). Self-reported tobacco, alcohol, and illicit drug use and progression of chronic kidney disease. Clinical Journal of the American Society of Nephrology: CJASN, 13(7), 993–1001. https://doi.org/https://doi.org/10.2215/CJN.11121017
- Delaney-Black, V., Chiodo, L. M., Hannigan, J. H., Greenwald, M. K., Janisse, J., Patterson, G., Huestis, M. A., Ager, J., & Sokol, R. J. (2010). Just say “I don't”: lack of concordance between teen report and biological measures of drug use. Pediatrics, 126(5), 887–893. https://doi.org/https://doi.org/10.1542/peds.2009-3059
- Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D., & Mokri, A. (2011). Characteristics of Iranian women seeking drug treatment. Journal of Women's Health, 20(11), 1687–1691. https://doi.org/https://doi.org/10.1089/jwh.2010.2694
- El Ansari, W., Vallentin-Holbech, L., & Stock, C. (2014). Predictors of illicit drug/s use among university students in Northern Ireland, Wales and England. Global Journal of Health Science, 7(4), 18. https://doi.org/https://doi.org/10.5539/gjhs.v7n4p18
- Forouhar, A., & Hasankhani, M. (2018). Urban renewal mega projects and residents’ quality of life: Evidence from historical religious center of Mashhad Metropolis. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 95(2), 232–244. https://doi.org/https://doi.org/10.1007/s11524-017-0224-4
- Ghiabi, M., Maarefvand, M., Bahari, H., & Alavi, Z. (2018). Islam and cannabis: Legalisation and religious debate in Iran. The International Journal on Drug Policy, 56, 121–127. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.03.009
- Gholami, A., & Ziaee, M. (2017). Development of a performance measurement system to choose the most efficient programs, the case of the Mashhad transportation system. Transportation Research Part A: Policy and Practice, 106, 261–277. https://doi.org/https://doi.org/10.1016/j.tra.2017.09.013
- Harrison, L. (1997). The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Research Monograph, 167, 17–36.
- Harrison, L., Hughes, A. (1997). The validity of self-reported drug use: Improving the accuracy of survey estimates (Vol. 167). US Department of Health and Human Services, National Institutes of Health.
- Harrison, L. D., Martin, S. S., Enev, T., & Harrington, D. (2007). Comparing drug testing and self-report of drug use among youths and young adults in the general population. Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
- Hawks, R. L., Chiang, C. N. (1986). Urine testing for drugs of abuse (Vol. 73). Department of Health and Human Services, Public Health Service, Alcohol.
- Hjorthøj, C. R., Hjorthøj, A. R., & Nordentoft, M. (2012). Validity of timeline follow-back for self-reported use of cannabis and other illicit substances-systematic review and meta-analysis. Addictive Behaviors, 37(3), 225–233. https://doi.org/https://doi.org/10.1016/j.addbeh.2011.11.025
- Hunt, D. E., Kling, R., Almozlino, Y., Jalbert, S., Chapman, M. T., & Rhodes, W. (2015). Telling the truth about drug use: How much does it matter? Journal of Drug Issues, 45(3), 314–329. https://doi.org/https://doi.org/10.1177/0022042615589406
- Khajedaluee, M., & Dadgar Moghadam, M. (2013). Methods and patterns of drug abuse among young addict women. Journal of Research and Health, 3(4), 527–535.
- Khajedaluee, M., Hassannia, T., Rezaee, A., Ziadi, M., & Dadgarmoghaddam, M. (2016). The prevalence of hypertension and its relationship with demographic factors, biochemical, and anthropometric indicators: A population-based study. ARYA Atherosclerosis, 12(6), 259–265.
- Khoei, E. M., Jamshidimanesh, M., Emamian, M. H., Sheikhan, F., Dolan, K., & Brady, K. T. (2018). Veiled truths: Iranian women and risky sexual behavior in the context of substance use. Journal of Reproduction & Infertility, 19(4), 237.
- Kuehn, B. M. (2017). KidneyNews.
- Li, D. H., Janulis, P., & Mustanski, B. (2019). Predictors of correspondence between self-reported substance use and urinalysis screening among a racially diverse cohort of young men who have sex with men and transgender women. Addictive Behaviors, 88, 6–14. https://doi.org/https://doi.org/10.1016/j.addbeh.2018.08.004
- Miller, P., Curtis, A., Jenkinson, R., Droste, N., Bowe, S. J., & Pennay, A. (2015). Drug use in Australian nightlife settings: estimation of prevalence and validity of self-report. Addiction (Abingdon, England), 110(11), 1803–1810. https://doi.org/https://doi.org/10.1111/add.13060
- Moeller, K. E., Lee, K. C., & Kissack, J. C. (2008). Urine drug screening: practical guide for clinicians [Paper presentation]. Paper Presented at the Mayo Clinic Proceedings. https://doi.org/https://doi.org/10.4065/83.1.66
- Napper, L. E., Fisher, D. G., Johnson, M. E., & Wood, M. M. (2010). The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users. Addictive Behaviors, 35(4), 350–354. https://doi.org/https://doi.org/10.1016/j.addbeh.2009.12.006
- Nikfarjam, A., Shokoohi, M., Shahesmaeili, A., Haghdoost, A. A., Baneshi, M. R., Haji-Maghsoudi, S., Rastegari, A., Nasehi, A. A., Memaryan, N., & Tarjoman, T. (2016). National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. The International Journal on Drug Policy, 31, 147–152. https://doi.org/https://doi.org/10.1016/j.drugpo.2016.01.013
- Novick, T., Liu, Y., Alvanzo, A., Zonderman, A. B., Evans, M. K., & Crews, D. C. (2016). Lifetime cocaine and opiate use and chronic kidney disease. American Journal of Nephrology, 44(6), 447–453. https://doi.org/https://doi.org/10.1159/000452348
- Ondersma, S. J., Chang, G., Blake‐Lamb, T., Gilstad‐Hayden, K., Orav, J., Beatty, J. R., Goyert, G. L., & Yonkers, K. A. (2019). Accuracy of five self‐report screening instruments for substance use in pregnancy. Addiction (Abingdon, England), 114(9), 1683–1693. https://doi.org/https://doi.org/10.1111/add.14651
- Palamar, J. J., Halkitis, P. N., & Kiang, M. V. (2013). Perceived public stigma and stigmatization in explaining lifetime illicit drug use among emerging adults. Addiction Research & Theory, 21(6), 516–525. https://doi.org/https://doi.org/10.3109/16066359.2012.762508
- Palamar, J. J., Kiang, M. V., & Halkitis, P. N. (2012). Predictors of stigmatization towards use of various illicit drugs among emerging adults. Journal of Psychoactive Drugs, 44(3), 243–251. https://doi.org/https://doi.org/10.1080/02791072.2012.703510
- Palamar, J. J., Le, A., Guarino, H., & Mateu-Gelabert, P. (2019). A comparison of the utility of urine-and hair testing in detecting self-reported drug use among young adult opioid users. Drug and Alcohol Dependence, 200, 161–167. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.04.008
- Parikh, R., Mathai, A., Parikh, S., Sekhar, G. C., & Thomas, R. (2008). Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology, 56(1), 45–50. https://doi.org/https://doi.org/10.4103/0301-4738.37595
- Rashidian, H., Hadji, M., Marzban, M., Gholipour, M., Rahimi-Movaghar, A., Kamangar, F., Malekzadeh, R., Weiderpass, E., Rezaianzadeh, A., Moradi, A., Babhadi-Ashar, N., Ghiasvand, R., Khavari-Daneshvar, H., Haghdoost, A. A., & Zendehdel, K. (2017). Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients. PloS One, 12(8), e0183017. https://doi.org/https://doi.org/10.1371/journal.pone.0183017
- Sarrami, H., Ghorbani, M., & Minooei, M. (2013). Survey of four decades of addiction prevalence researches in Iran. Research on Addiction, 7(26), 29–52.
- Sepanlou, S. G., Barahimi, H., Najafi, I., Kamangar, F., Poustchi, H., Shakeri, R., Hakemi, M. S., Pourshams, A., Khoshnia, M., Gharravi, A., Broumand, B., Nobakht-Haghighi, A., Kalantar-Zadeh, K., & Malekzadeh, R. (2017). Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study. PloS One, 12(5), e0176540. https://doi.org/https://doi.org/10.1371/journal.pone.0176540
- Simpson, M., & McNulty, J. (2008). Different needs: Women's drug use and treatment in the UK. International Journal of Drug Policy, 19(2), 169–175. https://doi.org/https://doi.org/10.1016/j.drugpo.2007.11.021
- Smith, P. C., Schmidt, S. M., Allensworth-Davies, D., & Saitz, R. (2010). A single-question screening test for drug use in primary care. Archives of Internal Medicine, 170(13), 1155–1160. https://doi.org/https://doi.org/10.1001/archinternmed.2010.140
- Tavakoli, M., Mohammadi, L., Yarmohammadi, M., Farhoudian, A., Ja'fari, F., & Farhadi, M. H. (2014). Status and trend of substance abuse and dependence among Iranian women. Archives of Rehabilitation, 14, 30–37.
- Trevethan, R. (2017). Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Frontiers in Public Health, 5, 307. https://doi.org/https://doi.org/10.3389/fpubh.2017.00307
- Turner, C. F., Lessler, J. T., Gfroerer, J. C. (1992). Survey measurement of drug use: Methodological studies. National Institute on Drug Abuse, Division of Epidemiology and Prevention.
- van den Berg, J. J., Adeyemo, S., Roberts, M. B., Bock, B. C., Stein, L. A. R., Martin, R. A., Parker, D. R., & Clarke, J. G. (2018). Comparing the validity of self-report and urinalysis for substance use among former inmates in the Northeastern United States: Substance use reporting accuracy among inmates. Subst Use Misuse, 53(10), 1756–1761. https://doi.org/https://doi.org/10.1080/10826084.2018.1432646
- Vearrier, D., Curtis, J. A., & Greenberg, M. I. (2010). Biological testing for drugs of abuse. In Molecular, clinical and environmental toxicology (pp. 489–517). Springer.
- Watson, P., & Petrie, A. (2010). Method agreement analysis: a review of correct methodology. Theriogenology, 73(9), 1167–1179. https://doi.org/https://doi.org/10.1016/j.theriogenology.2010.01.003
- Wish, E. D., Hoffman, J. A., & Nemes, S. (1997). The validity of self-reports of drug use at treatment admission and at follow-up: Comparisons with urinalysis and hair assays. NIDA Research Monograph, 167, 200–226.